Skip to main content

Albuterol

  • Chapter
  • 361 Accesses

Abstract

Bronchial asthma can be simply defined as reversible airways obstruction occurring in people with airways hypersensitivity. Since a major component of this obstruction is bronchospasm, the primary goal of asthma therapy is relief and/or prevention of bronchospasm. During the earlier part of this century, the mainstay for relief from the bronchospasm of acute severe asthmatic attacks was the endogenous adrenergic agonist, epinephrine (parenterally administered); it is still quite widely used, by subcutaneous injection, to relieve acute asthma. However, since the 1940s, the synthetic agent isoproterenol (injected and inhaled) has served as an alternative adrenergic bronchodilator for both the acute and sustained treatment of asthma, and from the 1960s onward, the synthetic adrenergic agonists metaproterenol, albuterol (salbutamol), terbutaline, and others, given by the inhalation and oral routes, have also come into wide usage.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahlquist, R. P.: A study of the adrenotropic receptors. Am.J. Physiol. 153: 586–600, 1948.

    PubMed  CAS  Google Scholar 

  • Armstrong, M. D., McMillan, A., and Shaw, K. N. F.: 3 Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim. Biophys. Ada 25:422,423,1957.

    Article  CAS  Google Scholar 

  • A very, G. S., ed.: Salbutamol: A review. Drugs 1:274–302, 1971.

    Google Scholar 

  • Axelrod, J.: O-Methylation of epinephrine and other catechols in vitro and in vivo. Science 126:400,401,1957.

    Article  PubMed  CAS  Google Scholar 

  • Barger, G. and Dale, H. H.: Chemical structure and sympathomimetic action of amines. J. Physiol. 41:19–59, 1910.

    PubMed  CAS  Google Scholar 

  • Bergman, J., Persson, H., and Wetterlin, K.: Two new groups of selective stimulants of adrenergic β-receptors. Experientia 25:899–901, 1969.

    Article  PubMed  CAS  Google Scholar 

  • Berkow, R., ed.: The Merck Manual, 14th Ed., Merck Sharp & Dohme Research Laboratories, Rah way, NJ, 1982.

    Google Scholar 

  • Brittain, R. T. and Harris, D. M.: Albuterol, in Pharmacological and Biochemical Properties of Drug Substances, vol. 1, M. E. Goldberg, ed., pp. 257–276, American Pharmaceutical Association Academy of Pharmaceutical Science, Washington, DC, 1977.

    Google Scholar 

  • Brittain, R. T., Dean, C. M., and Jack, D.: Sympathomimetic bronchodi-lator drugs. Pharmacol. Ther. [B] 2:423–62, 1976.

    Article  CAS  Google Scholar 

  • Brittain, R. T., Farmer, J. B., Jack, D., Martin, L. E., and Simpson, W. T.: at-[Butylamino)methyl]-4-hydroxy-m-xylene-a’,a3-diol (AH. 3365): A selective β-adrenergic stimulant. Nature 219:862,863,1968.

    Article  PubMed  CAS  Google Scholar 

  • Brittain, R. T., Jack, D., and Ritchie, A.C.: Recent β-adrenoreceptor stimulants, in Advance in Research, vol. 5, N. J. Harper and A. B. Simmonds, eds., pp. 197–253, Academic, London, 1970.

    Google Scholar 

  • Bronsky, E., Bucholtz, G. A., Busse, W. W., Chervinsky, P., Condemi, J., Ghafouri, M. A., Hudson, L., Lakshminarayan, S., Lockey, R., Reese, M. E., Rennard, S. I., Segal, A., Smolley, L., Spector, S., Stablein, J. J., Van As, A., and Wilson, A.: Comparison of inhaled albuterol powder and aerosol in asthma. J. Allergy Clin. Immunol. 79:741–747, 1987.

    Article  PubMed  CAS  Google Scholar 

  • Chervinsky, P.: Evaluation of a new selective beta-adrenergic receptor stimulant. Ann. Allergy 29:627–630, 1971.

    PubMed  CAS  Google Scholar 

  • Chervinsky, P.: Future drugs for the treatment of asthma, in Current Treatment of Ambulatory Asthma, G. A. Settipane, ed., pp. 120–122, New England and Regional Allergy Proceedings, Providence, 1986.

    Google Scholar 

  • Choo-Kang, Y. F. J., Parker, S. S., and Grant, I. W. B.: Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br. Med. J. 4:465–468, 1970.

    Article  PubMed  CAS  Google Scholar 

  • Choo-Kang, Y. F. J., Simpson, W. T., and Grant, I. W. B.: Controlled comparison of the bronchodilator effects of three β-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br. Med. J. 2:287–289, 1969.

    Article  PubMed  CAS  Google Scholar 

  • Chodosh, S.: Rational management of bronchial asthma. Arch. Intern. Med. 138:1394–1397, 1978.

    Article  PubMed  CAS  Google Scholar 

  • Collin, D. T., Hartley, D., Jack, D., Lunts, L. H. C., Press, J. C., Ritchie A. C., and Toon, P.: Saligenin analogs of sympathomimetic catechola-mines. J. Med. Chem. 13:674–680, 1970.

    Article  PubMed  CAS  Google Scholar 

  • Csáky, T. Z. and Barnes, B. A.: Cutting’s Handbookof Pharmacology, 7th Ed., Appleton-Century-Crofts, Norwalk, 1984.

    Google Scholar 

  • Cullum, V. A., Farmer, J. B., Jack, D., and Levy, G. P.: Salbutamol: A new selective β-adrenoceptive receptor stimulant. Br.J.Pharmcol. 35: 141–151, 1969.

    Article  CAS  Google Scholar 

  • Dunlop, D. and Shanks, R. G.: Selective blockade of adrenoceptive beta receptors in the heart. Br. J. Pharmacol. Chemother. 32:201–218, 1968.

    Article  PubMed  CAS  Google Scholar 

  • Dwyer, J. M.: Beta agonists in the management of asthma, in Current Treatment of Ambulatory Asthma, G. A. Settipane, ed., pp. 53–58, The New England and Regional Allergy Proceedings, Providence, 1986.

    Google Scholar 

  • Engelhardt, A., Hoefke, W., and Wick, H.: Pharmakologie des Sympatho-mimeticums l-(3,5-Dihydroxyphenyl)-l-hydroxy-2-isopropylamino-äthan. Arzneimittelforsch. 11: 521–525, 1961. (Read in translation in Drugs Made in Germany 4:123-131,1961.)

    PubMed  CAS  Google Scholar 

  • Gebbie, T.: Therapeutic choices in asthma, in Steroids in Asthma: A Re-appraisal in the Light of Inhalation Therapy, T. J. H. Clark, ed., pp. 83–102, Adis, Auckland, 1983.

    Google Scholar 

  • Hartley, D., Jack, D., Lunts, L. H. C., and Ritchie, A. C: New class of selective stimulants of beta-adrenergic receptors. Nature 219:861,862, 1968.

    Article  PubMed  CAS  Google Scholar 

  • Himori, N. and Taira, N.: Assessment of the selectivity of OPC-2009, a new β2-adrenoceptor stimulant, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br. J. Pharmacol. 61:9–17, 1977.

    Article  PubMed  CAS  Google Scholar 

  • Iafrate, R. P., Massey, K. L., and Hendeles, L.: Current concepts in clinical therapeutics: Asthma. Clin. Pharm. 5:206–227, 1986.

    PubMed  CAS  Google Scholar 

  • Jack, D.: Recent β-adrenoreceptor stimulants and the nature of β-adreno-receptors. Pharm. J. 205:237–240, 1970.

    CAS  Google Scholar 

  • Joad, J. P., Ahrens, R. C., Lindgren, S. D., and Weinberger, M. M.: Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J. Allergy Clin. Immunol. 79: 78–85, 1987.

    Article  PubMed  CAS  Google Scholar 

  • Kass, I. and Mingo, T.S.: Bitolterol mesylate (WIN32784)aerosol: Anew long-acting bronchodilator with reduced chronotropic effects. Chest 78:283–287, 1980.

    Article  PubMed  CAS  Google Scholar 

  • Kelman, G. R., Palmer, K. N. V., and Cross, M. R.: Cardiovascular effects of AH. 3365 (Salbutamol). Nature 221:1251, 1969.

    Article  PubMed  CAS  Google Scholar 

  • Konzett, H.: Neue broncholytische hochwirksame Körper der adrenalinreihe. Arch. Exp. Path. Pharmak. 197:27–40, 1940a.

    Article  CAS  Google Scholar 

  • Konzett, H.: Zur Pharmakolgie neuer adrenalinverwandter Körper. Arch. Exp. Path. Pharmak. 197:41–56, 1940b.

    Article  CAS  Google Scholar 

  • Lampe, K., ed. Drug Evaluations, 6th Ed., American Medical Association, Chicago, 1986.

    Google Scholar 

  • Lands, A. M. and Brown, T. G., Jr.: A comparison of the cardiac stimulating and bronchodilator actions of selected sympathomimetic amines. Proc. Soc. Exp. Biol. Med. 116:331–333, 1964.

    PubMed  CAS  Google Scholar 

  • Lands, A. M. and Howard, J. W.: A comparative study of the effects of 1-arterenol, epinephrine and isopropylarterenol on the heart. J. Pharmacol. Exper. Ther. 106:65–76, 1952.

    CAS  Google Scholar 

  • Lands, A. M., Groblewski, G. E., and Brown, T. G., Jr.: Comparison of the action of isoproterenol and several related compounds on blood pressure, heart and bronchioles. Arch. Pharmacodyn. Ther. 161:68–75, 1966.

    CAS  Google Scholar 

  • Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P., and Brown, T. G., Jr.: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597,598, 1967a.

    Article  PubMed  CAS  Google Scholar 

  • Lands, A. M., Luduena, F. P., and Buzzo, H. J.: Differentiation of receptors responsive to isoproterenol. Life Sci. 6:2241–2249, 1967b.

    Article  PubMed  CAS  Google Scholar 

  • Lands, A. M., Luduena, F. P., Grant, J. I., and E. Ananenko: The pharma-cologic action of some analogs of l-(3,4-dihydroxyphenyl)-2-amino-l-butanol (ethylnorepinephrine). J. Pharm. Exp. Ther. 99:45–56, 1950.

    CAS  Google Scholar 

  • Leif er, K. N. and Wittig, HJ.: The beta-2 sympa thomimetic aerosols in the treatment of asthma. Ann. Allergy 35:69–80, 1975.

    PubMed  CAS  Google Scholar 

  • Levy, B.: Dimethyl isopropylmethoxamine: A selective beta-receptor blocking agent. Br. J. Pharmacol. Chemother. 27:277–285, 1966.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, A. A. G., ed.: Salbutamol. Postgrad. Med. J. 47 (Suppl.): 1971.

    Google Scholar 

  • Minatoya, H.: Studies on bitolterol, di-p-toluate ester of N-tert-butylar-terenol: A new long-acting bronchodilator with reduced cardiovascular effects. J. Pharmacol. Exp. Ther. 206:515–527, 1978.

    PubMed  CAS  Google Scholar 

  • O’Donnell, S. R.: A selective ß-adrenoreceptor stimulant (TH1165a) related to orciprenaline. Eur. J. Pharmacol. 12:35–43, 1970.

    Article  PubMed  Google Scholar 

  • Palmer, K. N. V. and Diament, M. L.: Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. Br. Med. J. 1:31,32,1969.

    Article  PubMed  CAS  Google Scholar 

  • Prime, F.J.: Adrenergic receptors, bronchodilators and asthma. Drugs 1: 269–273, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Riding, W. D., Chatterjee, S. S., and Dinda, P.: Clinical trial of a new beta-adrenergic stimulant in asthma. Br. J. Clin. Prac. 23:217–219, 1969.

    CAS  Google Scholar 

  • Ross, S.B.: In vivoinactivation of catecholamines in mice. Acta Pharmacol, et Toxicol. 20:267–273, 1963.

    Article  CAS  Google Scholar 

  • Shanks, R. G.: The discovery of beta-adrenoceptor blocking agents. Trends Pharm. Sci. 5:405–409, 1984.

    Article  Google Scholar 

  • Sheller, J. R. and Snapper, J. R.: Asthma in adults and adolescents, in Conn’s Current Therapy, R. E. Rakel, ed., pp. 600–604, W. B. Saunders, Philadelphia, 1987.

    Google Scholar 

  • Tashkin, D. P. and Jenne, J. W.: Alpha and beta adrenergic agents, in Bronchial Asthma: Mechanisms and Therapeutics, 2nd Ed., E. B. Weiss, M. S. Segal, and M. Stein, eds., pp. 604–639, Little Brown, Boston, 1985.

    Google Scholar 

  • Tattersfield, A. E. and Mc Nicol, M.W.: Salbutamol and isoproterenol: A double-blind trial to compare bronchodilator and cardiovascular activity. N. Engl. J. Med. 281:1323–1326, 1969.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, D. R., Buick, B., Kinney, C., Lowry, R. C., and McDevitt, D. G.: The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am. Rev. Respir. Dis. 131:747–751, 1985.

    PubMed  CAS  Google Scholar 

  • Warrell, D. A., Robertson, D. G., Newton Howes, J., Conolly, M. E., Paterson, J. W. Beilin, L. J., and Dollery, C. T.: Comparison of cardio-respiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br. Med. J. 1:65–70, 1970.

    Article  PubMed  CAS  Google Scholar 

  • Weinstein, A. M.: Asthma, McGraw-Hill, New York, 1987.

    Google Scholar 

  • Williams, M. H.: Inhaled versus oral bronchodilators, in Current Treatment of Ambulatory Asthma, E. A. Settipane, ed., pp. 75–77, New England and Regional Allergy Proceedings, Providence, 1986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media New York

About this chapter

Cite this chapter

Maxwell, R.A., Eckhardt, S.B. (1990). Albuterol. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0469-5_25

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6775-1

  • Online ISBN: 978-1-4612-0469-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics